Skip to main content
. 2020 Sep 8;11:2116. doi: 10.3389/fmicb.2020.02116

FIGURE 5.

FIGURE 5

Efficacy of PGMC in combination with various antifungal agents against Candida albicans. (A) Combination effect of PGMC and antifungal agents against drug-resistant Candida albicans determined using checkerboard assays. (B) In vitro zone of inhibition assays using topical formulations containing no antifungal agent (placebo cream with PGMC), marketed formulation containing 1% clotrimazole and formulation containing 1% clotrimazole plus PGMC against Candida albicans (C) In vitro time kill kinetics of clotrimazole formulation containing PGMC versus marketed formulation of clotrimazole against C. albicans (D) Efficacy of clotrimazole (1%) formulation containing PGMC in a mouse model of cutaneous candidiasis. Fungal load was evaluated at designated time intervals during the efficacy experiment after treatment with antifungal formulations, clotrimazole (1%) topical cream containing PGMC/marketed cream of 1% clotrimazole. The infection control did not receive any treatment. Treatment time points were 24, 36, and 48 h post infection. The data is represented as mean ± SD (n = 4). Statistical analysis was performed using Student’s t-test (∗∗p < 0.005).